Cargando…
An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195299/ https://www.ncbi.nlm.nih.gov/pubmed/32363145 http://dx.doi.org/10.1016/j.hrcr.2020.03.016 |
| _version_ | 1783528504421253120 |
|---|---|
| author | Mitra, Raman L. Greenstein, Steven A. Epstein, Laurence M. |
| author_facet | Mitra, Raman L. Greenstein, Steven A. Epstein, Laurence M. |
| author_sort | Mitra, Raman L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7195299 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71952992020-05-26 An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine Mitra, Raman L. Greenstein, Steven A. Epstein, Laurence M. HeartRhythm Case Rep Case Report Elsevier 2020-04-01 /pmc/articles/PMC7195299/ /pubmed/32363145 http://dx.doi.org/10.1016/j.hrcr.2020.03.016 Text en © 2020 Published by Elsevier Inc. on behalf of Heart Rhythm Society. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Case Report Mitra, Raman L. Greenstein, Steven A. Epstein, Laurence M. An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine |
| title | An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine |
| title_full | An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine |
| title_fullStr | An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine |
| title_full_unstemmed | An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine |
| title_short | An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine |
| title_sort | algorithm for managing qt prolongation in coronavirus disease 2019 (covid-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: possible benefits of intravenous lidocaine |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195299/ https://www.ncbi.nlm.nih.gov/pubmed/32363145 http://dx.doi.org/10.1016/j.hrcr.2020.03.016 |
| work_keys_str_mv | AT mitraramanl analgorithmformanagingqtprolongationincoronavirusdisease2019covid19patientstreatedwitheitherchloroquineorhydroxychloroquineinconjunctionwithazithromycinpossiblebenefitsofintravenouslidocaine AT greensteinstevena analgorithmformanagingqtprolongationincoronavirusdisease2019covid19patientstreatedwitheitherchloroquineorhydroxychloroquineinconjunctionwithazithromycinpossiblebenefitsofintravenouslidocaine AT epsteinlaurencem analgorithmformanagingqtprolongationincoronavirusdisease2019covid19patientstreatedwitheitherchloroquineorhydroxychloroquineinconjunctionwithazithromycinpossiblebenefitsofintravenouslidocaine AT mitraramanl algorithmformanagingqtprolongationincoronavirusdisease2019covid19patientstreatedwitheitherchloroquineorhydroxychloroquineinconjunctionwithazithromycinpossiblebenefitsofintravenouslidocaine AT greensteinstevena algorithmformanagingqtprolongationincoronavirusdisease2019covid19patientstreatedwitheitherchloroquineorhydroxychloroquineinconjunctionwithazithromycinpossiblebenefitsofintravenouslidocaine AT epsteinlaurencem algorithmformanagingqtprolongationincoronavirusdisease2019covid19patientstreatedwitheitherchloroquineorhydroxychloroquineinconjunctionwithazithromycinpossiblebenefitsofintravenouslidocaine |